Sleep Disorders in Seniors

Several mechanisms change sleep architecture in normal aging, independent of sleep disorders: (1) Circadian phase advance — the internal biological clock shifts earlier with age, causing earlier sleepiness (8–9 PM) and earlier morning waking (4–5 AM). This is a normal circadian change, not a sleep disorder. (2) Reduced slow-wave sleep (deep sleep) — seniors spend significantly less time in N3 sleep, making sleep feel less restorative even when total sleep time is adequate. (3) Increased sleep fragmentation — more brief awakenings throughout the night from nocturia, pain, or lighter sleep stages. (4) Shorter REM sleep episodes early in the night. (5) Reduced sleep drive (homeostatic pressure) — the sleep pressure that builds during waking hours appears reduced in elderly. Total sleep need does not significantly decrease with aging (most experts recommend 7–9 hours), but sleep architecture becomes less efficient. The AHA and AASM recommend all adults ≥ 18 get 7–9 hours per night, and this applies to seniors as well.

Cognitive Behavioral Therapy for Insomnia (CBT-I) is a structured program that typically consists of 6–8 sessions with a trained therapist or psychologist. It combines sleep restriction, stimulus control, sleep hygiene, cognitive restructuring, and relaxation training. CBT-I has consistently shown 70–80% improvement in insomnia symptoms with durable long-term effects — significantly better than sleeping pills for chronic insomnia. Medicare Part B covers CBT-I when delivered by a psychiatrist, psychologist, or licensed clinical social worker for medically necessary insomnia. Coverage requires a physician referral and the provider must accept Medicare. Digital CBT-I programs (Sleepio, Somryst — FDA-cleared) may also be covered depending on the Medicare Advantage plan. If in-person CBT-I is unavailable, books ('Say Good Night to Insomnia' by Gregg Jacobs, 'The Sleep Solution' by W. Chris Winter) and free online CBT-I programs (CBT-I Coach app by VA) can provide self-directed CBT-I.

No — zolpidem (Ambien) is explicitly listed on the American Geriatrics Society 2023 Beers Criteria as a medication to AVOID in older adults. The FDA has also issued a 2019 boxed warning about complex sleep behaviors (sleep driving, sleepwalking, sleep eating) with Z-drugs. In seniors specifically, zolpidem causes: significantly increased fall and hip fracture risk (meta-analyses show 1.5–2x increased fall risk); morning sedation that persists 8–12+ hours in elderly due to slower drug metabolism; cognitive impairment including next-day confusion and memory gaps; and paradoxical agitation in some seniors. A pivotal study (Kripke et al., 2012) found that even < 18 hypnotic prescriptions per year was associated with 3.6x increased mortality risk — though this remains controversial. The bottom line: CBT-I should be tried first. If medication is truly needed, melatonin (0.5–5mg), low-dose doxepin (3–6mg), or an orexin antagonist (suvorexant, lemborexant) are safer options.

Observable signs to watch for: (1) Loud, irregular snoring — particularly snoring that stops and starts (apneic pauses). Ask the bed partner. (2) Witnessed apneas — the bed partner actually sees the person stop breathing, then gasp or choke. (3) Excessive daytime sleepiness — falling asleep during the day, difficulty driving, sleeping during conversations or meals. (4) Nocturia (urination 3+ times/night) — often caused by OSA-induced atrial natriuretic peptide release, not bladder problems. Many seniors take diuretics or restrict fluids unnecessarily when the real cause is sleep apnea. (5) Morning headaches — from nocturnal CO2 retention. (6) Memory and concentration problems. (7) Waking with dry mouth or sore throat. Diagnosis: home sleep testing (HST) is now standard and can be done with a small device worn at home for one night. Ask the primary care physician for a sleep study referral. Medicare Part B covers sleep studies for suspected OSA.

Many common senior medications disrupt sleep. The most important: (1) Diuretics — furosemide, hydrochlorothiazide taken in the afternoon or evening cause nocturia that fragments sleep. Time diuretics in the morning or early afternoon. (2) Beta-blockers — reduce melatonin production by blocking beta-adrenergic receptors in the pineal gland. Carvedilol and metoprolol are the main offenders. If insomnia is new after starting a beta-blocker, discuss timing or alternative with physician. (3) Corticosteroids (prednisone) — highly stimulating; take in the morning only. (4) Stimulants — theophylline for COPD, pseudoephedrine in cold medications. (5) SSRIs and SNRIs — commonly cause insomnia, particularly at initiation; may improve after 2–4 weeks. (6) Levodopa (Parkinson's medication) — can cause vivid dreams and sleep fragmentation. (7) Caffeine — metabolism slows with age; caffeine from a 3 PM coffee can still be active at midnight in an 80-year-old. Review all medications with a pharmacist for sleep-disrupting potential before starting hypnotics.

Yes — the relationship between sleep and Alzheimer's risk is well-established and bidirectional. During deep sleep (N3/slow-wave sleep), the brain's glymphatic system clears amyloid-beta and tau proteins — the proteins that accumulate in Alzheimer's disease. Sleep deprivation reduces glymphatic clearance and accelerates amyloid accumulation. Epidemiological evidence: a 2021 study (Sabia et al., Nature Communications) of 7,959 participants found that consistently sleeping ≤ 6 hours/night at age 50 was associated with 30% increased dementia risk. A 2023 meta-analysis found short sleep duration (< 7h) associated with 27% increased dementia risk, and long sleep (> 9h — which indicates underlying health problems) associated with 74% increased risk. Untreated sleep apnea independently increases dementia risk — possibly because nocturnal hypoxia accelerates tau pathology. Treating sleep apnea and improving sleep quality are potentially dementia-preventive interventions, though direct RCT evidence on dementia outcomes is still emerging.

Insomnia alone does not require assisted living. However, several sleep-related situations make AL appropriate: (1) Severe sleep apnea with cognitive or functional impairment — if OSA is causing significant daytime sleepiness, cognitive decline, or driving impairment, and the senior cannot reliably use CPAP alone, AL provides assistance with equipment setup and compliance monitoring. (2) Sundowning in dementia — seniors with dementia often experience severe circadian disruption with confusion and agitation in the evening/night ('sundowning'). Memory care units are specifically designed for nighttime safety in this context. (3) REM Sleep Behavior Disorder with injury risk — seniors who injure themselves acting out dreams may not be safe alone at night. AL or memory care with nighttime supervision addresses this. (4) Severe insomnia causing dangerous daytime impairment — falls from fatigue, inability to manage medications or self-care, or social isolation from sleep-related depression may indicate the need for AL support.